Rare diseases
Investigational molecules
Locations
Back to Slovakia30 clinical trials in Piestany, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)Study on the Effectiveness and Safety of Efgartigimod for Adults with Primary Sjögren's Syndrome
SlovakiaStudy on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions
SlovakiaStudy of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis and Inadequate Response to DMARD Therapy
SlovakiaStudy on Guselkumab for Treating Psoriatic Arthritis in Patients New to Biologic Therapy
SlovakiaStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
SlovakiaStudy on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments
SlovakiaA study to evaluate the effects of obicetrapib and ezetimibe on cholesterol levels in adults with type 2 diabetes or metabolic syndrome
SlovakiaA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
SlovakiaLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
SlovakiaStudy on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy
SlovakiaStudy on Anifrolumab for Adults with Chronic or Subacute Cutaneous Lupus Erythematosus Unresponsive to Antimalarial Therapy
SlovakiaStudy on Rosnilimab for Patients with Moderate to Severe Rheumatoid Arthritis
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials investigating treatments for systemic lupus erythematosus, cutaneous lupus, and primary Sjögren's syndrome. Research focuses on developing targeted therapies to manage symptoms and improve patient outcomes.
Studies evaluate new biological treatments and their long-term safety profiles.
Groundbreaking studies examining innovative treatments for atherosclerotic cardiovascular disease and atrial fibrillation. Trials focus on preventing major cardiovascular events and managing stroke risk.
Research aims to reduce cardiovascular mortality and improve treatment outcomes.
Clinical investigations targeting rheumatoid arthritis, psoriatic arthritis, and rotator cuff tendinopathy. Studies evaluate new therapeutic approaches for inflammatory joint conditions.
Research focuses on improving mobility and reducing disease progression.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
